Two Sigma Securities’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,058
Closed -$112K 3533
2023
Q1
$112K Buy
+11,058
New +$111K ﹤0.01% 2189

Other funds holding DALS

Two Sigma Securities's DALS Position: Q2 2023 in Review

Two Sigma Securities sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q2 2023, closing a stake of 11,058 shares — an estimated $112K sold.

Two Sigma Securities first reported a position in DALS in Q1 2023 and held it in 1 quarter. The position peaked at $112K in Q1 2023. 50 funds tracked by Wall St. Rank hold DALS as of Q2 2023.

  • Two Sigma Securities reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Securities sold 11,058 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $112K.
  • Two Sigma Securities first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q1 2023 and held it in 1 quarter.
  • Two Sigma Securities's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $112K in Q1 2023.
  • 50 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.